Advertisement

Topics

SpinalCyte Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2018

11:07 EDT 17 May 2018 | Businesswire

SpinalCyte, LLC

SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using Human Dermal Fibroblasts (HDFs), today announced poster presentations highlighting a recent double-blind, placebo controlled human trial of CybroCell™ HDFs to treat degenerative disc disease along with Superior Immune Modulation for Arthritis and Treatment of Acute Liver Failure.

Poster Presentation Details:

 

Title:

      Efficacy of CybroCell™ Fibroblast Intradiscal Cellular Therapy for Disc Degenerative Disease

LINK

Number:

776

Category:

Cell Therapies

Session:

Date & Time: Friday, May 18, 5:45P CDT

Location:

Stevens Salon C, D

Authors:

Pete O'Heeron1, Jesus Perez2, Javier Lopez2, Amit N. Patel3, Courtney Bartlett3, Thomas E. Ichim1
 

1SpinalCyte LLC, Houston, TX,2Institute for Regenerative Medicine, Baja, Mexico,3University of Miami, Miami, FL

 
 

Title:

      Treatment of Acute Liver Failure Using CybroCell™ Universal Donor Fibroblast Therapy

LINK

Number:

478

Category:

Cell Therapies

Session:

Date & Time: Thursday, May 17, 5:15P CDT

Location:

Stevens Salon C, D

Authors:

Thomas E. Ichim1, Courtney Bartlett2, Wei-Ping Min3, Amit N. Patel2, Pete O'Heeron1
 
1SpinalCyte LLC, Houston, TX,2University of Miami, Miami, FL,3University of Western Ontario, London, ON, Canada
 
 

Title:

      Superior Immune Modulation and Anti-Arthritic Activity by CybroCell™ Compared to Bone Marrow Mesenchymal Stem Cells.

LINK

Number:

231

Category:

Immunological Aspects of Gene and Cell Therapy

Session:

Date & Time: Thursday, May 17, 5:30P CDT

Location:

Stevens Salon C, D

Authors:

Thomas E. Ichim1, Courtney Bartlett2, Wei-Ping Min3, Amit N. Patel2, Pete O'Heeron1
 
1SpinalCyte LLC, Houston, TX,2University of Miami, Miami, FL,3University of Western Ontario, London, ON, Canada
 

About SpinalCyte, LLC

Based in Houston, Texas, SpinalCyte, LLC is a regenerative medicine company developing an innovative solution for spinal nucleus replacement using human dermal fibroblasts. Currently, SpinalCyte holds 25 U.S. and international issued patents and has filed for an additional 48 patents pending. Funded entirely by angel investors, SpinalCyte represents the next generation of medical advancement in cell therapy. Visit www.spinalcyte.com.

SpinalCyte, LLC
Investor Contact:
281.461.6211
info@spinalcyte.com
or
Media Contact:
Dan Keeney, APR, 832.467.2904
dan@dpkpr.com

NEXT ARTICLE

More From BioPortfolio on "SpinalCyte Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...